TY - JOUR
T1 - A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-tubulin in antibody-mediated rejection and cardiac allograft vasculopathy
AU - Nath, Dilip S.
AU - Tiriveedhi, Venkataswarup
AU - Basha, Haseeb Ilias
AU - Phelan, Donna
AU - Moazami, Nader
AU - Ewald, Gregory A.
AU - Mohanakumar, Thalachallour
PY - 2011/5/15
Y1 - 2011/5/15
N2 - Background: We determined the role of donor-specific antibodies (DSA) and antibodies (Abs) to self-antigens, collagen-V (Col-V), and K-α1-Tubulin (KAT) in pathogenesis of acute antibody-mediated rejection (AMR) and cardiac allograft vasculopathy (CAV) after human heart transplantation (HTx). METHODS.: One hundred thirty-seven HTx recipients, with 60 early period (≤12 months) and 77 late period (>12 months), were enrolled in this study. Circulating DSA was determined using LUMINEX. Abs against Col-I, II, IV, V, and KAT were measured using ELISA. Frequency of CD4+T helper cells (CD4+Th) secreting interferon (IFN)-γ, interleukin (IL)-5, -10, or -17 specific to self-antigens were determined using Enzyme Linked Immunosorbent Spot assay. RESULTS.: A significant association between AMR and DSA was demonstrated. Development of DSA in AMR patients correlated well with the development of auto-Abs to Col-V (AMR[+]: 383±72 μg/mL, AMR[-]: 172±49 μg/mL, P=0.033) and KAT (AMR[+]: 252±49 μg/mL, AMR[-]: 61±21 μg/mL, P=0.014). Patients who developed AMR demonstrated increased frequencies of CD4+Th secreting IFN-γ and IL-5 with reduction in IL-10 specific for Col-V/KAT. Patients diagnosed with CAV also developed DSA and auto-Abs to Col-V (CAV[+]: 835±142 μg/mL, CAV[-]: 242±68 μg/mL, P=0.025) and KAT (CAV[+]: 768±206 μg/mL, CAV[-]: 196±72 μg/mL, P=0.001) with increased frequencies of CD4+Th secreting IL-17 with reduction in IL-10 specific for Col-V/KAT. CONCLUSIONS.: Development of Abs to human leukocyte antigens and self-antigens are associated with increases in CD4+Th secreting IFN-γ and IL-5 in AMR and IL-17 in CAV, with reduction in CD4+Th secreting IL-10 in both AMR and CAV.
AB - Background: We determined the role of donor-specific antibodies (DSA) and antibodies (Abs) to self-antigens, collagen-V (Col-V), and K-α1-Tubulin (KAT) in pathogenesis of acute antibody-mediated rejection (AMR) and cardiac allograft vasculopathy (CAV) after human heart transplantation (HTx). METHODS.: One hundred thirty-seven HTx recipients, with 60 early period (≤12 months) and 77 late period (>12 months), were enrolled in this study. Circulating DSA was determined using LUMINEX. Abs against Col-I, II, IV, V, and KAT were measured using ELISA. Frequency of CD4+T helper cells (CD4+Th) secreting interferon (IFN)-γ, interleukin (IL)-5, -10, or -17 specific to self-antigens were determined using Enzyme Linked Immunosorbent Spot assay. RESULTS.: A significant association between AMR and DSA was demonstrated. Development of DSA in AMR patients correlated well with the development of auto-Abs to Col-V (AMR[+]: 383±72 μg/mL, AMR[-]: 172±49 μg/mL, P=0.033) and KAT (AMR[+]: 252±49 μg/mL, AMR[-]: 61±21 μg/mL, P=0.014). Patients who developed AMR demonstrated increased frequencies of CD4+Th secreting IFN-γ and IL-5 with reduction in IL-10 specific for Col-V/KAT. Patients diagnosed with CAV also developed DSA and auto-Abs to Col-V (CAV[+]: 835±142 μg/mL, CAV[-]: 242±68 μg/mL, P=0.025) and KAT (CAV[+]: 768±206 μg/mL, CAV[-]: 196±72 μg/mL, P=0.001) with increased frequencies of CD4+Th secreting IL-17 with reduction in IL-10 specific for Col-V/KAT. CONCLUSIONS.: Development of Abs to human leukocyte antigens and self-antigens are associated with increases in CD4+Th secreting IFN-γ and IL-5 in AMR and IL-17 in CAV, with reduction in CD4+Th secreting IL-10 in both AMR and CAV.
KW - Antibody-mediated rejection
KW - Cardiac allograft vasculopathy
KW - Cardiac transplantation
KW - Self-antigens
UR - https://www.scopus.com/pages/publications/79955535248
U2 - 10.1097/TP.0b013e318211d2f4
DO - 10.1097/TP.0b013e318211d2f4
M3 - Article
C2 - 21383658
AN - SCOPUS:79955535248
SN - 0041-1337
VL - 91
SP - 1036
EP - 1043
JO - Transplantation
JF - Transplantation
IS - 9
ER -